This brand name is authorized in Ecuador
The drug TRAVAD contains a combination of these active pharmaceutical ingredients (APIs):
1
Sodium phosphate
UNII 22ADO53M6F - SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
|
|
2
Sodium phosphate
UNII KH7I04HPUU - SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A06AG01 | Sodium phosphate | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AG Enemas |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EC | Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria | Identifier(s): 850-MEE-0315 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.